How Much Did Cognoa Raise?
Funding & Key Investors

Cognoa has successfully secured a total capital infusion of $15.4M, marking a significant milestone in its mission to revolutionize pediatric behavioral health. This trajectory of financial backing, which includes a recent strategic investment of $11.6M, underscores the market confidence in the company's ability to bridge critical gaps in early childhood diagnostic care. By leveraging advanced machine learning, the firm is positioning itself as a pivotal player in the digital health ecosystem, transforming how clinicians approach developmental assessments.

The company's growth narrative is defined by a commitment to clinical rigor and technological scalability. With the support of institutional partners, Cognoa has transitioned from early-stage development to a more mature enterprise-level operation, focusing on the widespread adoption of its FDA-authorized diagnostic tools. This capital allocation is expected to accelerate the deployment of its flagship solutions, ensuring that families receive timely and objective insights into their children's developmental health.